img

Global Sophocarpidine Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Sophocarpidine Market Insights, Forecast to 2034

Sophocarpidine (CAS:519-02-8) is a white acicular crystal or crystalline powder with bitter taste. It is the main raw material for the production of oxymatrine and widely used in the treatment of liver diseases.
Global Sophocarpidine market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Sophocarpidine industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Sophora flavescens Aiton is mainly distributed in Cina, India, Japan, North Korea, Siberia, Russia.
Report Covers
This report presents an overview of global Sophocarpidine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Sophocarpidine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Fujie Pharmaceutical
QHL Pharma
Select Botanical
Indena
TIANSHAN Pharmaceuticals
Selco Wirkstoffe Vertriebs GmbH
Jiangsu Tiansheng Pharmaceutical
Tiansheng Pharmaceutical
Hubei Zhongliao Chemical Co., LTD
Segment by Type
High Purity
Low Purity

Segment by Application


Pharmaceuticals
Pesticides
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Sophocarpidine plant distribution, commercial date of Sophocarpidine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Sophocarpidine introduction, etc. Sophocarpidine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Sophocarpidine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Sophocarpidine Product Introduction
1.2 Market by Type
1.2.1 Global Sophocarpidine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 High Purity
1.2.3 Low Purity
1.3 Market by Application
1.3.1 Global Sophocarpidine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Pharmaceuticals
1.3.3 Pesticides
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Sophocarpidine Sales Estimates and Forecasts 2018-2029
2.2 Global Sophocarpidine Revenue by Region
2.2.1 Global Sophocarpidine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Sophocarpidine Revenue by Region (2018-2024)
2.2.3 Global Sophocarpidine Revenue by Region (2024-2029)
2.2.4 Global Sophocarpidine Revenue Market Share by Region (2018-2029)
2.3 Global Sophocarpidine Sales Estimates and Forecasts 2018-2029
2.4 Global Sophocarpidine Sales by Region
2.4.1 Global Sophocarpidine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Sophocarpidine Sales by Region (2018-2024)
2.4.3 Global Sophocarpidine Sales by Region (2024-2029)
2.4.4 Global Sophocarpidine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Sophocarpidine Sales by Manufacturers
3.1.1 Global Sophocarpidine Sales by Manufacturers (2018-2024)
3.1.2 Global Sophocarpidine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Sophocarpidine in 2022
3.2 Global Sophocarpidine Revenue by Manufacturers
3.2.1 Global Sophocarpidine Revenue by Manufacturers (2018-2024)
3.2.2 Global Sophocarpidine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Sophocarpidine Revenue in 2022
3.3 Global Key Players of Sophocarpidine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Sophocarpidine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Sophocarpidine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Sophocarpidine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Sophocarpidine, Product Offered and Application
3.8 Global Key Manufacturers of Sophocarpidine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Sophocarpidine Sales by Type
4.1.1 Global Sophocarpidine Historical Sales by Type (2018-2024)
4.1.2 Global Sophocarpidine Forecasted Sales by Type (2024-2029)
4.1.3 Global Sophocarpidine Sales Market Share by Type (2018-2029)
4.2 Global Sophocarpidine Revenue by Type
4.2.1 Global Sophocarpidine Historical Revenue by Type (2018-2024)
4.2.2 Global Sophocarpidine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Sophocarpidine Revenue Market Share by Type (2018-2029)
4.3 Global Sophocarpidine Price by Type
4.3.1 Global Sophocarpidine Price by Type (2018-2024)
4.3.2 Global Sophocarpidine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Sophocarpidine Sales by Application
5.1.1 Global Sophocarpidine Historical Sales by Application (2018-2024)
5.1.2 Global Sophocarpidine Forecasted Sales by Application (2024-2029)
5.1.3 Global Sophocarpidine Sales Market Share by Application (2018-2029)
5.2 Global Sophocarpidine Revenue by Application
5.2.1 Global Sophocarpidine Historical Revenue by Application (2018-2024)
5.2.2 Global Sophocarpidine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Sophocarpidine Revenue Market Share by Application (2018-2029)
5.3 Global Sophocarpidine Price by Application
5.3.1 Global Sophocarpidine Price by Application (2018-2024)
5.3.2 Global Sophocarpidine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Sophocarpidine Market Size by Type
6.1.1 US & Canada Sophocarpidine Sales by Type (2018-2029)
6.1.2 US & Canada Sophocarpidine Revenue by Type (2018-2029)
6.2 US & Canada Sophocarpidine Market Size by Application
6.2.1 US & Canada Sophocarpidine Sales by Application (2018-2029)
6.2.2 US & Canada Sophocarpidine Revenue by Application (2018-2029)
6.3 US & Canada Sophocarpidine Market Size by Country
6.3.1 US & Canada Sophocarpidine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Sophocarpidine Sales by Country (2018-2029)
6.3.3 US & Canada Sophocarpidine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Sophocarpidine Market Size by Type
7.1.1 Europe Sophocarpidine Sales by Type (2018-2029)
7.1.2 Europe Sophocarpidine Revenue by Type (2018-2029)
7.2 Europe Sophocarpidine Market Size by Application
7.2.1 Europe Sophocarpidine Sales by Application (2018-2029)
7.2.2 Europe Sophocarpidine Revenue by Application (2018-2029)
7.3 Europe Sophocarpidine Market Size by Country
7.3.1 Europe Sophocarpidine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Sophocarpidine Sales by Country (2018-2029)
7.3.3 Europe Sophocarpidine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Sophocarpidine Market Size
8.1.1 China Sophocarpidine Sales (2018-2029)
8.1.2 China Sophocarpidine Revenue (2018-2029)
8.2 China Sophocarpidine Market Size by Application
8.2.1 China Sophocarpidine Sales by Application (2018-2029)
8.2.2 China Sophocarpidine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Sophocarpidine Market Size by Type
9.1.1 Asia Sophocarpidine Sales by Type (2018-2029)
9.1.2 Asia Sophocarpidine Revenue by Type (2018-2029)
9.2 Asia Sophocarpidine Market Size by Application
9.2.1 Asia Sophocarpidine Sales by Application (2018-2029)
9.2.2 Asia Sophocarpidine Revenue by Application (2018-2029)
9.3 Asia Sophocarpidine Sales by Region
9.3.1 Asia Sophocarpidine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Sophocarpidine Revenue by Region (2018-2029)
9.3.3 Asia Sophocarpidine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Sophocarpidine Market Size by Type
10.1.1 Middle East, Africa and Latin America Sophocarpidine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Sophocarpidine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Sophocarpidine Market Size by Application
10.2.1 Middle East, Africa and Latin America Sophocarpidine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Sophocarpidine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Sophocarpidine Sales by Country
10.3.1 Middle East, Africa and Latin America Sophocarpidine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Sophocarpidine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Sophocarpidine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Fujie Pharmaceutical
11.1.1 Fujie Pharmaceutical Company Information
11.1.2 Fujie Pharmaceutical Overview
11.1.3 Fujie Pharmaceutical Sophocarpidine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Fujie Pharmaceutical Sophocarpidine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Fujie Pharmaceutical Recent Developments
11.2 QHL Pharma
11.2.1 QHL Pharma Company Information
11.2.2 QHL Pharma Overview
11.2.3 QHL Pharma Sophocarpidine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 QHL Pharma Sophocarpidine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 QHL Pharma Recent Developments
11.3 Select Botanical
11.3.1 Select Botanical Company Information
11.3.2 Select Botanical Overview
11.3.3 Select Botanical Sophocarpidine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Select Botanical Sophocarpidine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Select Botanical Recent Developments
11.4 Indena
11.4.1 Indena Company Information
11.4.2 Indena Overview
11.4.3 Indena Sophocarpidine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Indena Sophocarpidine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Indena Recent Developments
11.5 TIANSHAN Pharmaceuticals
11.5.1 TIANSHAN Pharmaceuticals Company Information
11.5.2 TIANSHAN Pharmaceuticals Overview
11.5.3 TIANSHAN Pharmaceuticals Sophocarpidine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 TIANSHAN Pharmaceuticals Sophocarpidine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 TIANSHAN Pharmaceuticals Recent Developments
11.6 Selco Wirkstoffe Vertriebs GmbH
11.6.1 Selco Wirkstoffe Vertriebs GmbH Company Information
11.6.2 Selco Wirkstoffe Vertriebs GmbH Overview
11.6.3 Selco Wirkstoffe Vertriebs GmbH Sophocarpidine Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Selco Wirkstoffe Vertriebs GmbH Sophocarpidine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Selco Wirkstoffe Vertriebs GmbH Recent Developments
11.7 Jiangsu Tiansheng Pharmaceutical
11.7.1 Jiangsu Tiansheng Pharmaceutical Company Information
11.7.2 Jiangsu Tiansheng Pharmaceutical Overview
11.7.3 Jiangsu Tiansheng Pharmaceutical Sophocarpidine Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Jiangsu Tiansheng Pharmaceutical Sophocarpidine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Jiangsu Tiansheng Pharmaceutical Recent Developments
11.8 Tiansheng Pharmaceutical
11.8.1 Tiansheng Pharmaceutical Company Information
11.8.2 Tiansheng Pharmaceutical Overview
11.8.3 Tiansheng Pharmaceutical Sophocarpidine Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Tiansheng Pharmaceutical Sophocarpidine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Tiansheng Pharmaceutical Recent Developments
11.9 Hubei Zhongliao Chemical Co., LTD
11.9.1 Hubei Zhongliao Chemical Co., LTD Company Information
11.9.2 Hubei Zhongliao Chemical Co., LTD Overview
11.9.3 Hubei Zhongliao Chemical Co., LTD Sophocarpidine Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Hubei Zhongliao Chemical Co., LTD Sophocarpidine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Hubei Zhongliao Chemical Co., LTD Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Sophocarpidine Industry Chain Analysis
12.2 Sophocarpidine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Sophocarpidine Production Mode & Process
12.4 Sophocarpidine Sales and Marketing
12.4.1 Sophocarpidine Sales Channels
12.4.2 Sophocarpidine Distributors
12.5 Sophocarpidine Customers
13 Market Dynamics
13.1 Sophocarpidine Industry Trends
13.2 Sophocarpidine Market Drivers
13.3 Sophocarpidine Market Challenges
13.4 Sophocarpidine Market Restraints
14 Key Findings in The Global Sophocarpidine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Sophocarpidine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of High Purity
Table 3. Major Manufacturers of Low Purity
Table 4. Global Sophocarpidine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Sophocarpidine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Sophocarpidine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Sophocarpidine Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Sophocarpidine Revenue Market Share by Region (2018-2024)
Table 9. Global Sophocarpidine Revenue Market Share by Region (2024-2029)
Table 10. Global Sophocarpidine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Sophocarpidine Sales by Region (2018-2024) & (K MT)
Table 12. Global Sophocarpidine Sales by Region (2024-2029) & (K MT)
Table 13. Global Sophocarpidine Sales Market Share by Region (2018-2024)
Table 14. Global Sophocarpidine Sales Market Share by Region (2024-2029)
Table 15. Global Sophocarpidine Sales by Manufacturers (2018-2024) & (K MT)
Table 16. Global Sophocarpidine Sales Share by Manufacturers (2018-2024)
Table 17. Global Sophocarpidine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Sophocarpidine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Sophocarpidine, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Sophocarpidine Price by Manufacturers 2018-2024 (USD/MT)
Table 21. Global Sophocarpidine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Sophocarpidine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sophocarpidine as of 2022)
Table 23. Global Key Manufacturers of Sophocarpidine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Sophocarpidine, Product Offered and Application
Table 25. Global Key Manufacturers of Sophocarpidine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Sophocarpidine Sales by Type (2018-2024) & (K MT)
Table 28. Global Sophocarpidine Sales by Type (2024-2029) & (K MT)
Table 29. Global Sophocarpidine Sales Share by Type (2018-2024)
Table 30. Global Sophocarpidine Sales Share by Type (2024-2029)
Table 31. Global Sophocarpidine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Sophocarpidine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Sophocarpidine Revenue Share by Type (2018-2024)
Table 34. Global Sophocarpidine Revenue Share by Type (2024-2029)
Table 35. Sophocarpidine Price by Type (2018-2024) & (USD/MT)
Table 36. Global Sophocarpidine Price Forecast by Type (2024-2029) & (USD/MT)
Table 37. Global Sophocarpidine Sales by Application (2018-2024) & (K MT)
Table 38. Global Sophocarpidine Sales by Application (2024-2029) & (K MT)
Table 39. Global Sophocarpidine Sales Share by Application (2018-2024)
Table 40. Global Sophocarpidine Sales Share by Application (2024-2029)
Table 41. Global Sophocarpidine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Sophocarpidine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Sophocarpidine Revenue Share by Application (2018-2024)
Table 44. Global Sophocarpidine Revenue Share by Application (2024-2029)
Table 45. Sophocarpidine Price by Application (2018-2024) & (USD/MT)
Table 46. Global Sophocarpidine Price Forecast by Application (2024-2029) & (USD/MT)
Table 47. US & Canada Sophocarpidine Sales by Type (2018-2024) & (K MT)
Table 48. US & Canada Sophocarpidine Sales by Type (2024-2029) & (K MT)
Table 49. US & Canada Sophocarpidine Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Sophocarpidine Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Sophocarpidine Sales by Application (2018-2024) & (K MT)
Table 52. US & Canada Sophocarpidine Sales by Application (2024-2029) & (K MT)
Table 53. US & Canada Sophocarpidine Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Sophocarpidine Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Sophocarpidine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Sophocarpidine Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Sophocarpidine Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Sophocarpidine Sales by Country (2018-2024) & (K MT)
Table 59. US & Canada Sophocarpidine Sales by Country (2024-2029) & (K MT)
Table 60. Europe Sophocarpidine Sales by Type (2018-2024) & (K MT)
Table 61. Europe Sophocarpidine Sales by Type (2024-2029) & (K MT)
Table 62. Europe Sophocarpidine Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Sophocarpidine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Sophocarpidine Sales by Application (2018-2024) & (K MT)
Table 65. Europe Sophocarpidine Sales by Application (2024-2029) & (K MT)
Table 66. Europe Sophocarpidine Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Sophocarpidine Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Sophocarpidine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Sophocarpidine Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Sophocarpidine Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Sophocarpidine Sales by Country (2018-2024) & (K MT)
Table 72. Europe Sophocarpidine Sales by Country (2024-2029) & (K MT)
Table 73. China Sophocarpidine Sales by Type (2018-2024) & (K MT)
Table 74. China Sophocarpidine Sales by Type (2024-2029) & (K MT)
Table 75. China Sophocarpidine Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Sophocarpidine Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Sophocarpidine Sales by Application (2018-2024) & (K MT)
Table 78. China Sophocarpidine Sales by Application (2024-2029) & (K MT)
Table 79. China Sophocarpidine Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Sophocarpidine Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Sophocarpidine Sales by Type (2018-2024) & (K MT)
Table 82. Asia Sophocarpidine Sales by Type (2024-2029) & (K MT)
Table 83. Asia Sophocarpidine Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Sophocarpidine Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Sophocarpidine Sales by Application (2018-2024) & (K MT)
Table 86. Asia Sophocarpidine Sales by Application (2024-2029) & (K MT)
Table 87. Asia Sophocarpidine Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Sophocarpidine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Sophocarpidine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Sophocarpidine Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Sophocarpidine Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Sophocarpidine Sales by Region (2018-2024) & (K MT)
Table 93. Asia Sophocarpidine Sales by Region (2024-2029) & (K MT)
Table 94. Middle East, Africa and Latin America Sophocarpidine Sales by Type (2018-2024) & (K MT)
Table 95. Middle East, Africa and Latin America Sophocarpidine Sales by Type (2024-2029) & (K MT)
Table 96. Middle East, Africa and Latin America Sophocarpidine Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Sophocarpidine Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Sophocarpidine Sales by Application (2018-2024) & (K MT)
Table 99. Middle East, Africa and Latin America Sophocarpidine Sales by Application (2024-2029) & (K MT)
Table 100. Middle East, Africa and Latin America Sophocarpidine Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Sophocarpidine Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Sophocarpidine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Sophocarpidine Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Sophocarpidine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Sophocarpidine Sales by Country (2018-2024) & (K MT)
Table 106. Middle East, Africa and Latin America Sophocarpidine Sales by Country (2024-2029) & (K MT)
Table 107. Fujie Pharmaceutical Company Information
Table 108. Fujie Pharmaceutical Description and Major Businesses
Table 109. Fujie Pharmaceutical Sophocarpidine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 110. Fujie Pharmaceutical Sophocarpidine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Fujie Pharmaceutical Recent Developments
Table 112. QHL Pharma Company Information
Table 113. QHL Pharma Description and Major Businesses
Table 114. QHL Pharma Sophocarpidine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 115. QHL Pharma Sophocarpidine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. QHL Pharma Recent Developments
Table 117. Select Botanical Company Information
Table 118. Select Botanical Description and Major Businesses
Table 119. Select Botanical Sophocarpidine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 120. Select Botanical Sophocarpidine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Select Botanical Recent Developments
Table 122. Indena Company Information
Table 123. Indena Description and Major Businesses
Table 124. Indena Sophocarpidine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 125. Indena Sophocarpidine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Indena Recent Developments
Table 127. TIANSHAN Pharmaceuticals Company Information
Table 128. TIANSHAN Pharmaceuticals Description and Major Businesses
Table 129. TIANSHAN Pharmaceuticals Sophocarpidine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 130. TIANSHAN Pharmaceuticals Sophocarpidine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. TIANSHAN Pharmaceuticals Recent Developments
Table 132. Selco Wirkstoffe Vertriebs GmbH Company Information
Table 133. Selco Wirkstoffe Vertriebs GmbH Description and Major Businesses
Table 134. Selco Wirkstoffe Vertriebs GmbH Sophocarpidine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 135. Selco Wirkstoffe Vertriebs GmbH Sophocarpidine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Selco Wirkstoffe Vertriebs GmbH Recent Developments
Table 137. Jiangsu Tiansheng Pharmaceutical Company Information
Table 138. Jiangsu Tiansheng Pharmaceutical Description and Major Businesses
Table 139. Jiangsu Tiansheng Pharmaceutical Sophocarpidine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 140. Jiangsu Tiansheng Pharmaceutical Sophocarpidine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Jiangsu Tiansheng Pharmaceutical Recent Developments
Table 142. Tiansheng Pharmaceutical Company Information
Table 143. Tiansheng Pharmaceutical Description and Major Businesses
Table 144. Tiansheng Pharmaceutical Sophocarpidine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 145. Tiansheng Pharmaceutical Sophocarpidine Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Tiansheng Pharmaceutical Recent Developments
Table 147. Hubei Zhongliao Chemical Co., LTD Company Information
Table 148. Hubei Zhongliao Chemical Co., LTD Description and Major Businesses
Table 149. Hubei Zhongliao Chemical Co., LTD Sophocarpidine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 150. Hubei Zhongliao Chemical Co., LTD Sophocarpidine Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Hubei Zhongliao Chemical Co., LTD Recent Developments
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Sophocarpidine Distributors List
Table 155. Sophocarpidine Customers List
Table 156. Sophocarpidine Market Trends
Table 157. Sophocarpidine Market Drivers
Table 158. Sophocarpidine Market Challenges
Table 159. Sophocarpidine Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Sophocarpidine Product Picture
Figure 2. Global Sophocarpidine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Sophocarpidine Market Share by Type in 2022 & 2029
Figure 4. High Purity Product Picture
Figure 5. Low Purity Product Picture
Figure 6. Global Sophocarpidine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Sophocarpidine Market Share by Application in 2022 & 2029
Figure 8. Pharmaceuticals
Figure 9. Pesticides
Figure 10. Others
Figure 11. Sophocarpidine Report Years Considered
Figure 12. Global Sophocarpidine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Sophocarpidine Revenue 2018-2029 (US$ Million)
Figure 14. Global Sophocarpidine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Sophocarpidine Revenue Market Share by Region (2018-2029)
Figure 16. Global Sophocarpidine Sales 2018-2029 ((K MT)
Figure 17. Global Sophocarpidine Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Sophocarpidine Sales YoY (2018-2029) & (K MT)
Figure 19. US & Canada Sophocarpidine Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Sophocarpidine Sales YoY (2018-2029) & (K MT)
Figure 21. Europe Sophocarpidine Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Sophocarpidine Sales YoY (2018-2029) & (K MT)
Figure 23. China Sophocarpidine Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Sophocarpidine Sales YoY (2018-2029) & (K MT)
Figure 25. Asia (excluding China) Sophocarpidine Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Sophocarpidine Sales YoY (2018-2029) & (K MT)
Figure 27. Middle East, Africa and Latin America Sophocarpidine Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Sophocarpidine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Sophocarpidine in the World: Market Share by Sophocarpidine Revenue in 2022
Figure 30. Global Sophocarpidine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Sophocarpidine Sales Market Share by Type (2018-2029)
Figure 32. Global Sophocarpidine Revenue Market Share by Type (2018-2029)
Figure 33. Global Sophocarpidine Sales Market Share by Application (2018-2029)
Figure 34. Global Sophocarpidine Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Sophocarpidine Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Sophocarpidine Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Sophocarpidine Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Sophocarpidine Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Sophocarpidine Revenue Share by Country (2018-2029)
Figure 40. US & Canada Sophocarpidine Sales Share by Country (2018-2029)
Figure 41. U.S. Sophocarpidine Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Sophocarpidine Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Sophocarpidine Sales Market Share by Type (2018-2029)
Figure 44. Europe Sophocarpidine Revenue Market Share by Type (2018-2029)
Figure 45. Europe Sophocarpidine Sales Market Share by Application (2018-2029)
Figure 46. Europe Sophocarpidine Revenue Market Share by Application (2018-2029)
Figure 47. Europe Sophocarpidine Revenue Share by Country (2018-2029)
Figure 48. Europe Sophocarpidine Sales Share by Country (2018-2029)
Figure 49. Germany Sophocarpidine Revenue (2018-2029) & (US$ Million)
Figure 50. France Sophocarpidine Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Sophocarpidine Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Sophocarpidine Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Sophocarpidine Revenue (2018-2029) & (US$ Million)
Figure 54. China Sophocarpidine Sales Market Share by Type (2018-2029)
Figure 55. China Sophocarpidine Revenue Market Share by Type (2018-2029)
Figure 56. China Sophocarpidine Sales Market Share by Application (2018-2029)
Figure 57. China Sophocarpidine Revenue Market Share by Application (2018-2029)
Figure 58. Asia Sophocarpidine Sales Market Share by Type (2018-2029)
Figure 59. Asia Sophocarpidine Revenue Market Share by Type (2018-2029)
Figure 60. Asia Sophocarpidine Sales Market Share by Application (2018-2029)
Figure 61. Asia Sophocarpidine Revenue Market Share by Application (2018-2029)
Figure 62. Asia Sophocarpidine Revenue Share by Region (2018-2029)
Figure 63. Asia Sophocarpidine Sales Share by Region (2018-2029)
Figure 64. Japan Sophocarpidine Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Sophocarpidine Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Sophocarpidine Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Sophocarpidine Revenue (2018-2029) & (US$ Million)
Figure 68. India Sophocarpidine Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Sophocarpidine Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Sophocarpidine Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Sophocarpidine Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Sophocarpidine Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Sophocarpidine Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Sophocarpidine Sales Share by Country (2018-2029)
Figure 75. Brazil Sophocarpidine Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Sophocarpidine Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Sophocarpidine Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Sophocarpidine Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Sophocarpidine Revenue (2018-2029) & (US$ Million)
Figure 80. Sophocarpidine Value Chain
Figure 81. Sophocarpidine Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed